Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Selective inhibition of human diploid fibroblast collagen synthesis by interferons.
S A Jimenez, … , B Freundlich, J Rosenbloom
S A Jimenez, … , B Freundlich, J Rosenbloom
Published September 1, 1984
Citation Information: J Clin Invest. 1984;74(3):1112-1116. https://doi.org/10.1172/JCI111480.
View: Text | PDF
Research Article Article has an altmetric score of 3

Selective inhibition of human diploid fibroblast collagen synthesis by interferons.

  • Text
  • PDF
Abstract

The effects of alpha- and gamma-interferons (IFNs) on collagen production by confluent human diploid fibroblasts in culture were examined. It was found that partially purified alpha-IFNs and affinity purified gamma-IFNs caused greater than 50% inhibition of collagen synthesis by these cells independently of their effect on cell proliferation. Recombinant alpha-IFNs showed a similar effect (38.8% inhibition), indicating that collagen synthesis inhibition was a constitutive property of IFNs. Collagen synthesis inhibition by IFNs was concentration dependent. Gel filtration chromatography of the newly synthesized proteins from the media of fibroblasts incubated with partially purified alpha-IFNs demonstrated a selective depression of molecules eluting in the region of procollagen. No detectable increase in collagen degradation products or underhydroxylation of procollagen was observed. Short-term kinetic studies further demonstrated that the major effect of IFNs was due to a net decrease in fibroblast collagen production rather than to impairment of secretion or increased extracellular degradation of the newly synthesized molecules. These results indicate that alpha- and gamma-IFNs are potent inhibitors of human fibroblast collagen production and suggest that they may play an important role in the regulation of normal and pathologic fibrogenesis.

Authors

S A Jimenez, B Freundlich, J Rosenbloom

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 Total
Citations: 1 1 1 2 6 2 1 3 1 2 2 4 6 3 3 6 9 6 11 3 9 11 10 7 8 13 8 7 15 12 14 10 12 9 11 10 7 8 8 6 268
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (268)

Title and authors Publication Year
Perspective to precision medicine in scleroderma.
Komura K, Yanaba K, Bouaziz JD, Yoshizaki A, Hasegawa M, Varga J, Takehara K, Matsushita T
Frontiers in immunology 2024
Morphea: The 2023 update.
Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ
Frontiers in Medicine 2023
Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.
Arai T, Hirose M, Hamano Y, Kagawa T, Murakami A, Kida H, Kumanogoh A, Inoue Y
2022
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review
M Zhao, J Wu, H Wu, AH Sawalha, Q Lu
Clinical Reviews in Allergy & Immunology 2021
SHP2 : The protein tyrosine phosphatase involved in chronic pulmonary inflammation and fibrosis
CJ Chang, CF Lin, BC Chen, PY Lin, CL Chen
IUBMB Life 2021
RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
L Zhytnik, K Maasalu, E Reimann, A Märtson, S Kõks
BMC Medical Genomics 2020
An Uromodulin mutation drives autoimmunity and kidney mononuclear phagocyte endoplasmic reticulum stress
M Plotkin, CA OBrien, J Goellner, J Williams, W Carter, S Sharma, A Stone
The American Journal of Pathology 2020
Handbook of Burns Volume 2: Reconstruction and Rehabilitation
LP Kamolz, MG Jeschke, RE Horch, M Küntscher, P Brychta
2020
Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function
S Steffens, SV Linthout, JP Sluijter, CG Tocchetti, T Thum, R Madonna
Cardiovascular Research 2020
Keloids: A Review of Etiology, Prevention, and Treatment
Udayan Betarbet, Travis W Blalock
The Journal of clinical and aesthetic dermatology 2020
Cryosurgery as a Single Agent and in Combination with Intralesional Corticosteroids Is Effective on Young, Small Keloids and Induces Characteristic Histological and Immunohistological Changes: A Prospective Randomized Trial
CC Zouboulis, E Zouridaki
Dermatology 2020
Concomitant Infection of S. mansoni and H. pylori Promotes Promiscuity of Antigen-Experienced Cells and Primes the Liver for a Lower Fibrotic Response
S Bhattacharjee, R Mejías-Luque, E Loffredo-Verde, A Toska, M Flossdorf, M Gerhard, CP da Costa
Cell Reports 2019
Handbook of Burns Volume 1: Acute Burn Care
MG Jeschke, LP Kamolz, F Sjöberg, SE Wolf
2019
Cardiac (myo)fibroblasts modulate the migration of monocyte subsets
K Pappritz, K Savvatis, A Koschel, K Miteva, C Tschöpe, SV Linthout
Scientific Reports 2018
The Immunology of Cardiovascular Homeostasis and Pathology
S Sattler, T Kennedy-Lydon
The Immunology of Cardiovascular Homeostasis and Pathology 2017
The Immunology of Cardiovascular Homeostasis and Pathology
S Sattler, T Kennedy-Lydon
The Immunology of Cardiovascular Homeostasis and Pathology 2017
Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions
S Amini-Nik, Y Yousuf, MG Jeschke
Advanced Drug Delivery Reviews 2017
Skin Tissue Engineering and Regenerative Medicine
BL Allen-Hoffmann, PJ Rooney
Skin Tissue Engineering and Regenerative Medicine 2016
Immunopathogenesis of Myocarditis: The Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4 + T Cells
BP Amoah, H Yang, P Zhang, Z Su, H Xu
Scandinavian Journal of Immunology 2015
Interferon γ and tumor necrosis factor α: novel biomarkers for assessment of different grades of hepatic periportal fibrosis due to Schistosoma mansoni infestation
AS Abdelhaleem, AM Ghafour, MA Rafek
Egyptian Liver Journal 2015
Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis: Gene Expression in SSc-Related Progressive Lung Fibrosis
RB Christmann, P Sampaio-Barros, G Stifano, CL Borges, CR de Carvalho, R Kairalla, ER Parra, A Spira, R Simms, VL Capellozzi, R Lafyatis
Arthritis & Rheumatology 2014
Crosstalk between fibroblasts and inflammatory cells
SV Linthout, K Miteva, C Tschope
Cardiovascular Research 2014
Native human interferon-a is a strong inductor of endogenous cytokines involved in the suppression of procollagen type I
G Šantak, M Šantak, D Forčić
Biomedicine & Pharmacotherapy 2013
Effect of lipopolysaccharide on the biological characteristics of human skin fibroblasts and hypertrophic scar tissue formation: Effect of LPS on Scar Tissue
H Yang, C Hu, F Li, L Liang, L Liu
IUBMB Life 2013
Management of keloids and hypertrophic scars: current and emerging options
GG Gauglitz
Clinical, cosmetic and investigational dermatology 2013
Intralesional Treatment for Keloids and Hypertrophic Scars: A Review
JA Ledon, J Savas, K Franca, A Chacon, K Nouri
Dermatologic Surgery 2013
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines
M Hasegawa, K Takehara
Seminars in Arthritis and Rheumatism 2012
Les cytokines dans la sclérodermie systémique
J Baraut, D Farge, F Jean-Louis, H Kesmandt, C Durant, F Verrecchia, L Michel
Pathologie Biologie 2012
Cutaneous manifestations of acute radiation exposure: a review: Cutaneous manifestations of acute radiation exposure
KA Ward, JP Jaimes, NV Coots
International Journal of Dermatology 2012
Handbook of Burns
MG Jeschke, LP Kamolz, F Sjöberg, SE Wolf
2012
Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer
A Haydaroglu, G Ozyigit
2012
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts
SK Agarwal, M Wu, CK Livingston, DH Parks, MD Mayes, FC Arnett, FK Tan
Arthritis Research & Therapy 2011
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice
I Badea, C Virtanen, RE Verrall, A Rosenberg, M Foldvari
Gene Therapy 2011
The Pathogenesis of Systemic Sclerosis Revisited
M Geyer, U Müller-Ladner
Clinical Reviews in Allergy & Immunology 2010
Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies
GG Gauglitz, HC Korting, T Pavicic, T Ruzicka, MG Jeschke
Molecular Medicine 2010
Innovative therapies in the treatment of keloids and hypertrophic scars
MH Viera, S Amini, W Valins, B Berman
The Journal of clinical and aesthetic dermatology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Recent Advances in the Treatment of Systemic Sclerosis
VK Bournia, PG Vlachoyiannopoulos, C Selmi, HM Moutsopoulos, ME Gershwin
Clinical Reviews in Allergy & Immunology 2009
Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents
PJ Wermuth, FD Galdo, SA Jiménez
Arthritis & Rheumatism 2009
Keloid Scarring: New Treatments Ahead
U Mrowietz, O Seifert
Actas Dermo-Sifiliográficas 2009
Atlas of Cosmetic Surgery
S Batra, C Chen, TE Rohrer
Atlas of Cosmetic Surgery 2009
Failure of Imiquimod 5% Cream to Prevent Recurrence of Surgically Excised Trunk Keloids:
FM Cação, V Tanaka, MC de Messina
Dermatologic Surgery 2009
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
Wound healing in radiated skin: pathophysiology and treatment options
A Olascoaga, D Vilar-Compte, A Poitevin-Chacón, J Contreras-Ruiz
International Wound Journal 2008
Effects of interferon-α2b on keloid treatment with triamcinolone acetonide intralesional injection
JH Lee, SE Kim, AY Lee
International Journal of Dermatology 2008
Fibrosis in Systemic Sclerosis
JA Varga, M Trojanowska
Rheumatic Disease Clinics of North America 2008
Baculovirus-mediated interferon alleviates dimethylnitrosamine-induced liver cirrhosis symptoms in a murine model
Y Nishibe, H Kaneko, H Suzuki, T Abe, Y Matsuura, H Takaku
Gene Therapy 2008
Levels of evidence for the treatment of keloid disease
P Durani, A Bayat
Journal of Plastic, Reconstructive & Aesthetic Surgery 2008
Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis
I Badea, M Taylor, A Rosenberg, M Foldvari
Rheumatology 2008
ROLE OF ANTIFIBROTIC CYTOKINE INTERFERON-γ IN THE PREVENTION OF POSTLAMINECTOMY PERIDURAL FIBROSIS IN RATS
H Emmez, O Kardes, F Dogulu, G Kurt, L Memis, MK Baykaner
Neurosurgery 2008
Prevention and Management of Hypertrophic Scars and Keloids After Burns in Children
B Berman, MH Viera, S Amini, R Huo, IS Jones
Journal of Craniofacial Surgery 2008
SYSTEMIC SCLEROSIS: A PROTOTYPIC MULTISYSTEM FIBROTIC DISORDER
John Varga and David Abraham
Journal of Clinical Investigation 2007
Native Human IFN-αIs a More Potent Suppressor of HDF Response to Profibrotic Stimuli Than Recombinant Human IFN-α
G Šantak, M Šantak, D Forčić
Journal of Interferon & Cytokine Research 2007
Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts
RB Jalili, GR Rayat, RV Rajotte, A Ghahary
Journal of Cellular Physiology 2007
Effect of Prolonged Interferon Therapy on the Outcome of Hepatitis C Virus–Related Cirrhosis: A Randomized Trial
L Fartoux, F Degos, C Trépo, O Goria, P Calès, A Tran, C Buffet, T Poynard, D Capron, JJ Raabe, D Roulot, S Naveau, JD Grange, RE Poupon, R Poupon, L Serfaty
Clinical Gastroenterology and Hepatology 2007
Influence of Pretransplant IFN-Alpha Therapy on Interstitial Fibrosis in Renal Allografts with Hepatitis C Virus Infection
BH Özdemir, FN Özdemir, S Sezer, M Haberal
Renal Failure 2007
Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma
Soocheol Jeong, Hiroshi Aikata, Yoshio Katamura, Takahiro Azakami, Tomokazu Kawaoka, Hiromi Saneto, Kiminori Uka, Nami Mori, Shintaro Takaki, Hideaki Kodama, Koji Waki, Michio Imamura, Hiroo Shirakawa, Yoshiiku Kawakami, Shoichi Takahashi, Kazuaki Chayama
World journal of gastroenterology : WJG 2007
Prevention of hepatic fibrosis in nonobese diabetic mice: a critical role for interferon-gamma
T Mukai, M Nagaki, M Imose, K Kimura, S Satake, S Takai, H Moriwaki
Liver International 2006
Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin
N Louneva, G Huaman, J Fertala, SA Jiménez
Arthritis & Rheumatism 2006
The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
T Yamamoto
Archives of Dermatological Research 2006
Topical Interferon-??2b and Keloid Treatment: A Place for Pretreatment?
AC Uysal
Plastic and Reconstructive Surgery 2006
Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery
II Tasci, MR Mas, SA Vural, B Comert, G Alcigir, M Serdar, N Mas, AT Isik, Y Ates
Liver International 2006
Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ)
AK Ghosh, S Bhattacharyya, Y Mori, J Varga
Journal of Cellular Physiology 2006
Letter: Experience with Keloids after Excision and Application of 5% Imiquimod Cream
PJ Patel, RO SKINNER
Dermatologic Surgery 2006
Linear Hypopigmentation After Triamcinolone Injection: A Rare Complication of a Common Procedure
V Nanda, MA Parwaz, S Handa
Aesthetic Plastic Surgery 2006
Experience with Keloids after Excision and Application of 5% Imiquimod Cream:
PJ Patel, RO SKINNER
Dermatologic Surgery 2006
Cytokine Gene Polymorphisms in Multifactorial Conditions
T Laitinen
Cytokine Gene Polymorphisms in Multifactorial Conditions 2006
Treatment of Keloids and Hypertrophic Scars: A Meta-analysis and Review of the Literature
D Leventhal, M Furr, D Reiter
ARCH FACIAL PLAST S 2006
Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B
DM Lebensztejn, ME Sobaniec-Łotowska, M Bauer, M Kaczmarski, M Voelker, D Schuppan
European Journal of Gastroenterology & Hepatology 2005
First case series on the use of imiquimod for morphoea
M Dytoc, PT Ting, J Man, D Sawyer, L Fiorillo
British Journal of Dermatology 2005
Double-Blind, Randomized, Placebo-Controlled, Prospective Study Evaluating the Tolerability and Effectiveness of Imiquimod Applied to Postsurgical Excisions on Scar Cosmesis
B Berman, S Frankel, AM Villa, CC Ramirez, V Poochareon, K Nouri
Dermatologic Surgery 2005
Bone metabolism during interferon-alpha treatment of essential thrombocythemia
R Kusec, V Kusec, B Gisslinger, W Woloszczuk, H Gisslinger
Wiener klinische Wochenschrift 2004
Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production
RJ Hodges, RG Jenkins, CP Wheeler-Jones, DM Copeman, SE Bottoms, GJ Bellingan, CB Nanthakumar, GJ Laurent, SL Hart, ML Foster, RJ McAnulty
The American Journal of Pathology 2004
Significance of the cytokine interferon gamma in clinical dermatology
A Grassegger, R Hopfl
Clinical and Experimental Dermatology 2004
Medical and surgical therapies for keloids
AP Kelly
Dermatologic Therapy 2004
Is systemic sclerosis an antigen-driven T cell disease?
LI Sakkas, CD Platsoucas
Arthritis & Rheumatism 2004
Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis
A Dessein, B Kouriba, C Eboumbou, H Dessein, L Argiro, S Marquet, NE Elwali, V Rodrigues, Y Li, O Doumbo, C Chevillard
Immunological Reviews 2004
ROLE OF PHENERGAN IN ABNORMAL SCARS AND KELOIDS
J Venugopal, V Jayaraman, M Babu, S Ramakrishna
Journal of Biological Systems 2004
Infectious Disease and Host-Pathogen Evolution
KR Dronamraju
2004
Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon γ (IFN-γ)
Y Xu, L Wang, G Butticè, PK Sengupta, BD Smith
The Journal of biological chemistry 2004
Parenchymal transforming growth factor beta-1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology
F Calabrese, M Valente, C Giacometti, E Pettenazzo, L Benvegnu, A Alberti, A Gatta, P Pontisso
Journal of Gastroenterology and Hepatology 2003
Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis
SE Jacob, B Berman, M Nassiri, V Vincek
British Journal of Dermatology 2003
Imiquimod 5% Cream for Keloid Management
B Berman, A Villa
Dermatologic Surgery 2003
Extracellular Matrix and the Liver
MJ Arthur
Extracellular Matrix and the Liver 2003
Animal Models of Human Inflammatory Skin Diseases: Induction by Bleomycin
T Yamamoto
Animal Models of Human Inflammatory Skin Diseases: Induction by Oral Allergen 2003
Fibroproliferative scars
SR Rahban, WL Garner
Clinics in Plastic Surgery 2003
Imiquimod 5% Cream for Keloid Management:
B Berman, A Villa
Dermatologic Surgery 2003
Interferon γ Repression of Collagen ( COL1A2 ) Transcription Is Mediated by the RFX5 Complex
Y Xu, L Wang, G Butticè, PK Sengupta, BD Smith
The Journal of biological chemistry 2003
Phase II study of ?2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): A trial of the Eastern Cooperative Oncology Group
AI Radin, HT Kim, BW Grant, JM Bennett, JM Kirkwood, JA Stewart, RG Hahn, JP Dutcher, PH Wiernik, MM Oken
Cancer 2003
Mechanisms of Spontaneous Resolution versus Fibrosis in Granulomatous Experimental Autoimmune Thyroiditis
K Chen, Y Wei, GC Sharp, H Braley-Mullen
Journal of immunology (Baltimore, Md. : 1950) 2003
IFN-γ Polymorphisms (IFN-γ +2109 and IFN-γ +3810) Are Associated with Severe Hepatic Fibrosis in Human Hepatic Schistosomiasis ( Schistosoma mansoni )
C Chevillard, CE Moukoko, NE Elwali, JH Bream, B Kouriba, L Argiro, S Rahoud, A Mergani, S Henri, J Gaudart, Q Mohamed-Ali, HA Young, AJ Dessein
Journal of immunology (Baltimore, Md. : 1950) 2003
Murine animal models of systemic sclerosis
SA Jimenez, PJ Christner
Current Opinion in Rheumatology 2002
Animal Model of Sclerotic Skin Induced by Bleomycin: A Clue to the Pathogenesis of and Therapy for Scleroderma?
T Yamamoto
Clinical Immunology 2002
Keratinocytes Inhibit Expression of Connective Tissue Growth Factor in Fibroblasts In Vitro by an Interleukin-1alpha-Dependent Mechanism
D Nowinski, P Hoijer, T Engstrand, K Rubin, B Gerdin, M Ivarsson
Journal of Investigative Dermatology 2002
Endotoxin exposure in allergy and asthma: Reconciling a paradox
AH Liu
Journal of Allergy and Clinical Immunology 2002
Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids
B Berman, J Kaufman
Journal of the American Academy of Dermatology 2002
Interferons: unapproved uses, dosages, or indications
E Orion, H Matz, R Wolf
Clinics in Dermatology 2002
Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice
G Izbicki, R Or, TG Christensen, MJ Segel, A Fine, RH Goldstein, R Breuer
American journal of physiology. Lung cellular and molecular physiology 2002
Scar Management: Keloid, Hypertrophic, Atrophic, and Acne Scars
SS Tsao, JS Dover, KA Arndt, MS Kaminer
Seminars in Cutaneous Medicine and Surgery 2002
Inhibition of Basal and Transforming Growth Factor-β-induced Stimulation of COL1A1 Transcription by the DNA Intercalators, Mitoxantrone and WP631, in Cultured Human Dermal Fibroblasts
S Gaidarova, SA Jiménez
The Journal of biological chemistry 2002
Cytokine Regulation of Periportal Fibrosis in Humans Infected with Schistosoma mansoni : IFN-γ Is Associated with Protection Against Fibrosis and TNF-α with Aggravation of Disease
S Henri, C Chevillard, A Mergani, P Paris, J Gaudart, C Camilla, H Dessein, F Montero, NE Elwali, OK Saeed, M Magzoub, AJ Dessein
Journal of immunology (Baltimore, Md. : 1950) 2002
The protein kinase C delta inhibitor, rottlerin, downregulates collagen gene expression in normal and systemic sclerosis fibroblasts
Sergio A. Jimenez, Svetlana Gaidarova, Biagio Saitta, Nora Sandorfi, David J. Herrich, Joan C. Rosenbloom, Umberto Kucich, William R. Abrams, Joel Rosenbloom
Journal of Clinical Investigation 2001
Antiproliferative Effects of IFN-αCorrelate with the Downregulation of Nuclear Factor-κB in Human Burkitt Lymphoma Daudi Cells
PC Rath, BB Aggarwal
Journal of Interferon & Cytokine Research 2001
Interferon-gamma in 5 patients with cutaneous radiation syndrome after radiation therapy
P Gottlöber, M Steinert, W Bähren, L Weber, H Gerngroß, RU Peter
International journal of radiation oncology, biology, physics 2001
Myofibroblasts and apoptosis in human hypertrophic scars: The effect of interferon-α2b
B Nedelec, H Shankowsky, PG Scott, A Ghahary, EE Tredget
Surgery 2001
Attenuation of Lung Inflammation and Fibrosis in Interferon- γ –Deficient Mice after Intratracheal Bleomycin
ES Chen, BM Greenlee, M Wills-Karp, DR Moller
American journal of respiratory cell and molecular biology 2001
A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen α2(I) and Other Promoters
XS Zhu, JP Ting
Molecular and cellular biology 2001
Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III
F Serejo, A Costa, A G Oliveira, F Ramalho, A Batista, M C De Moura
Digestive Diseases and Sciences 2001
The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide
SJ Oliver
Current Rheumatology Reports 2000
The effect of retreatment with interferon-? on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
H Toyoda, T Kumada, S Nakano, I Takeda, K Sugiyama, S Kiriyama, Y Sone, Y Hisanaga
Cancer 2000
The Role of the Immune System in Conjunctival Wound Healing After Glaucoma Surgery
L Chang, JG Crowston, MF Cordeiro, AN Akbar, PT Khaw
Survey of Ophthalmology 2000
Elevated Interleukin-6 Expression in Keloid Fibroblasts
H Xue, RL McCauley, W Zhang
Journal of Surgical Research 2000
Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C
A Mitsuda, T Suou, Y Ikuta, H Kawasaki
Journal of Hepatology 2000
Immune Stimulation in Scleroderma Patients Treated with Thalidomide
SJ Oliver, A Moreira, G Kaplan
Clinical Immunology 2000
Lack of Interferon-γ Production Despite the Presence of Interleukin-18 During Cutaneous Wound Healing
H Kämpfer, J Paulukat, H Mühl, C Wetzler, J Pfeilschifter, S Frank
Molecular Medicine 2000
Cellular Mechanisms in Airways Inflammation
CP Page, KH Banner, D Spina
2000
A randomized phase II trial of interferon-α2b versus 5-fluorouracil after trabeculectomy*
MC Gillies, AM Brooks, S Young, B Gillies, JM Simpson, I Goldberg
Australian and New Zealand Journal of Ophthalmology 1999
The effect of the anti-allergic agent avil on abnormal scar fibroblasts
J Venugopal
Burns 1999
Role of nitric oxide in the antifibrotic and anticholestatic actions of interferon-?2b
P Muriel
Drug Development Research 1999
Interferon-gamma inhibits experimental renal fibrosis
SD Oldroyd, GL Thomas, G Gabbiani, AM el Nahas
Kidney International 1999
Bullous keloid: a distinct entity?
Pranteda, Bottoni, De Simone, Calvieri, Grieco
British Journal of Dermatology 1999
On the Nature of Hypertrophic Scars and Keloids: A Review
FB Niessen, PH Spauwen, J Schalkwijk, M Kon
Plastic & Reconstructive Surgery 1999
Keloids and hypertrophic scars: Review and treatment strategies
SS Urioste, KA Arndt, JS Dover
Seminars in Cutaneous Medicine and Surgery 1999
Interferon gamma in survivors of the Chernobyl power plant accident: new therapeutic option for radiation-induced fibrosis
RU Peter, P Gottlöber, N Nadeshina, G Krähn, O Braun-Falco, G Plewig
International journal of radiation oncology, biology, physics 1999
Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosis
H Tsushima, S Kawata, S Tamura, N Ito, Y Shirai, S Kiso, Y Doi, A Yamada, O Oshikawa, Y Matsuzawa
Journal of Hepatology 1999
Severe Hepatic Fibrosis in Schistosoma mansoni Infection Is Controlled by a Major Locus That Is Closely Linked to the Interferon-γ Receptor Gene
AJ Dessein, D Hillaire, NE Elwali, S Marquet, Q Mohamed-Ali, A Mirghani, S Henri, AA Abdelhameed, OK Saeed, MM Magzoub, L Abel
The American Journal of Human Genetics 1999
Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis
SP Atamas, VV Yurovsky, R Wise, FM Wigley, CJ Robinson, P Henry, WJ Alms, B White
Arthritis & Rheumatism 1999
Increased Levels of Alternatively Spliced Interleukin 4 (IL-4δ2) Transcripts in Peripheral Blood Mononuclear Cells from Patients with Systemic Sclerosis
LI Sakkas, C Tourtellotte, S Berney, AR Myers, CD Platsoucas
Clinical Diagnostic Laboratory Immunology 1999
Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha
T Ninomiya, S Yoon, M Sugano, Y Kumon, Y Seo, K Shimizu, H Nagano, M Kasuga, Y Hayashi
Digestive Diseases and Sciences 1999
Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: Different sensitivity to inhibition between systemic sclerosis and control fibroblasts
C Chizzolini, R Rezzonico, C Ribbens, D Burger, FA Wollheim, JM Dayer
Arthritis & Rheumatism 1998
Semiquantitative measurement of total extracellular matrix protein produced by cultured mesangial cells
T OOTAKA, N KRAFT, T SAITO, RC ATKINS
Nephrology 1998
The pathogenesis of cutaneous fibrosis
B Liu, MK Connolly
Seminars in Cutaneous Medicine and Surgery 1998
Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivo
I Sakaida, K Uchida, Y Matsumura, K Okita
Journal of Hepatology 1998
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method
V Duchatelle, P Marcellin, E Giostra, L Bregeaud, M Pouteau, N Boyer, A Auperin, S Guerret, S Erlinger, D Henin, C Degott
Journal of Hepatology 1998
Determinants of outcome of compensated hepatitis C virus-related cirrhosis: Determinants of Outcome of Compensated Hepatitis C Virus-Related Cirrhosis
L Serfaty, H Aumaître, O Chazouillères, AM Bonnand, O Rosmorduc, RE Poupon, R Poupon
Hepatology 1998
Long term treatment of myeloproliferative disease with interferon-?-2b: Feasibility and efficacy
HS Gilbert
Cancer 1998
Biological and Hormonal Therapies of Cancer
KA Foon, HB Muss
1998
Regulations of collagen synthesis by ascorbic acid, transforming growth factor-β and interferon-γ in human dermal fibroblasts cultured in three-dimensional collagen gel are photoaging- and aging-independent
JH Chung, SH Youn, OS Kwon, KH Cho, JI Youn, HC Eun
Journal of Dermatological Science 1997
Bleomycin-induced lung injury is enhanced by interferon-α
N Berkman, RH Goldstein, R Breuer
Life Sciences 1997
Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms
A Diaz, SA Jiménez
The International Journal of Biochemistry & Cell Biology 1997
Growth Hormone, Skin and Wound Healing-experimental studies in the rat
PH Jørgensen
APMIS 1997
Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures
H Serpier, P Gillery, V Salmon-Ehr, R Garnotel, N Georges, B Kalis, FX Maquart
Journal of Investigative Dermatology 1997
Regulation of Type I Collagen mRNA by Amino Acid Deprivation in Human Lung Fibroblasts
M Krupsky, PP Kuang, RH Goldstein
The Journal of biological chemistry 1997
Strategies for Immunointerventions in Dermatology
G Burg, RG Dummer
1997
Effects of Interferon-α Treatment on Neutrophil Oxidative Metabollsm, Lymphocyte Prollferation and Monocyte HLA Class I Antigen Expression in Patients with Chronic Hepatitis C
G Piazzolla, G Giannelli, G Antonelli, C Tortorella, E Jirillo, O Schiraldi, S Antonaci
Immunopharmacology and Immunotoxicology 1996
Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon
M Arai, M Niioka, K Maruyama, N Wada, N Fujimoto, T Nomiyama, S Tanaka, I Okazaki
Digestive Diseases and Sciences 1996
Inhibition of collagen expression by azelastine hydrochloride in cultured skin fibroblasts from normal individuals and scleroderma patients
H Yamada, S Tajima
Archives of Dermatological Research 1996
FAILURE OF INTERFERON-ALPHA 2B IN THE TREATMENT OF MATURE KELOIDS
MM Al-Khawajah
International Journal of Dermatology 1996
Keloid Excision and Recurrence Prophylaxis Via Intradermal Interferon-Gamma Injections: A Pilot Study
BJ Broker, D Rosen, J Amsberry, R Schmidt, L Sailor, EA Pribitkin, WM Keane
The Laryngoscope 1996
Interferon gamma differentially affects the synthesis of chondroitin/dermatan sulphate and heparan sulphate by human skin fibroblasts
C Praillet, H Lortat-Jacob, JA Grimaud
Biochemical Journal 1996
The effects of 5-fluorouracil and interferon-alpha on early healing of experimental intestinal anastomoses
JW de Waard, T Wobbes, BM de Man, CJ van der Linden, T Hendriks
British Journal of Cancer 1996
The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factorbinding sites
K Mori, A Hatamochi, H Ueki, A Olsen, SA Jimenez
Biochemical Journal 1996
PATHOGENESIS OF SCLERODERMA
SA Jimenez, E Hitraya, J Varga
Rheumatic Disease Clinics of North America 1996
Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat
P Muriel
Journal of Hepatology 1996
Interferon-γ inhibits 35S incorporation in heparan sulfate synthesized by human skin fibroblasts
C Praillet, H Lortat-Jacob, JA Grimaud
FEBS Letters 1996
Potential Use of Interferon-α in Ophthalmological Disorders
MC Gillies
Clinical immunotherapeutics 1996
Topical interferon alpha 2b for corneal haze after excimer laser photorefractive keratectomy
MC Gillies, SK Garrett, SM Shina, N Morlet, HR Taylor
Journal of Cataract & Refractive Surgery 1996
Triple Helix-forming Oligonucleotide Corresponding to the Polypyrimidine Sequence in the Rat 1(I) Collagen Promoter Specifically Inhibits Factor Binding and Transcription
A Kovacs, JC Kandala, KT Weber, RV Guntaka
The Journal of biological chemistry 1996
Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis
PG Vlachoyiannopoulos, N Tsifetaki, I Dimitriou, D Galaris, SA Papiris, HM Moutsopoulos
Annals of the rheumatic diseases 1996
Regulation of Type I Collagen Genes Expression
G Karsenty, RW Park
International Reviews of Immunology 1995
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
A Mallat, AM Preaux, S Blazejewski, J Rosenbaum, D Dhumeaux, P Mavier
Hepatology 1995
Inhibition of Type I Collagen mRNA Expression Independent of Tryptophan Depletion in Interferon-gamma-Treated Human Dermal Fibroblasts
T Yufit, V Vining, L Wang, RR Brown, J Varga
Journal of Investigative Dermatology 1995
Pentoxifylline, Pentifylline, and Interferons Decrease Type I and III Procollagen mRNA Levels in Dermal Fibroblasts: Evidence for Mediation by Nuclear Factor 1 Down-Regulation
MR Duncan, A Hasan, B Berman
Journal of Investigative Dermatology 1995
Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa
T Suou, K Hosho, Y Kishimoto, Y Horie, H Kawasaki
Hepatology 1995
Modulation of experimental mesangial proliferative nephritis by interferon-γ
RJ Johnson, D Lombardi, E Eng, K Gordon, CE Alpers, P Pritzl, J Floege, B Young, J Pippin, WG Couser, G Gabbiani
Kidney International 1995
Molecular organization of the interferon gamma-binding domain in heparan sulphate
H Lortat-Jacob, JE Turnbull, JA Grimaud
Biochemical Journal 1995
Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha
N Hiramatus, N Hayashi, A Kasahara, H Hagiwara, T Takehara, Y Haruna, M Naito, H Fusamoto, T Kamada
Journal of Hepatology 1995
Remission of liver fibrosis by interferon-α2b
MG Moreno, P Muriel
Biochemical Pharmacology 1995
Molecular Mechanisms of Antifibrotic Effect of Interferon Gamma in Bleomycin-Mouse Model of Lung Fibrosis: Downregulation of TGF-β and Procollagen I and III Gene Expression
G Gurujeyalakshmi, SN Giri
Experimental Lung Research 1995
Histomorphologic Changes in Keloids Treated with Kenacort:
C Boyadjiev, E Popchristova, J Mazgalova
The Journal of Trauma: Injury, Infection and Critical Care 1995
Screening of potent inhibitors of collagen synthesis in cultured human skin fibroblasts
H Yamada, T Shigematsu, S Tajima, T Nishikawa
Archives of Dermatological Research 1995
CUTANEOUS SCARS: PART I
WJ Sahl, H Clever
International Journal of Dermatology 1994
Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis
SG Ramos, AP Montenegro, G Goissis, MA Rossi
Pathology International 1994
Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes
MB Goldring, K Fukuo, JR Birkhead, E Dudek, LJ Sandell
Journal of Cellular Biochemistry 1994
Influence of epidermal growth factor and interferon γ on healing of oesophageal corrosive burns in the rat
B Berthet, JD Costanzo, C Arnaud, R Choux, R Assadourian
British Journal of Surgery 1994
Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-α
JC Teran, KD Mullen, JH Hoofnagle, AJ McCullough
Hepatology 1994
Dose and Regimen Effects of Poly ICLC, an Interferon Inducer, in a Multi-Dose Bleomycin Model of Interstitial Pulmonary Fibrosis
JS Wild, DM Hyde, SN Giri
Pharmacology & Toxicology 1994
Keloids and hypertrophic scars
JC Murray
Clinics in Dermatology 1994
Lymphocyte modulation of fibroblast function in systemic sclerosis
TH Piela-Smith, JH Korn
Clinics in Dermatology 1994
Interferon-gamma, an Anti-fibrogenic Cytokine which Binds to Heparan Sulfate
H Lortat-Jacob, P Esterre, JA Grimaud
Pathology - Research and Practice 1994
Effects of interferon-alfa and the herbal medicine Sho-saiko-to on cytokine production and lung fibroblast proliferation
H Suganuma, A Sato, R Tamura, K Chida
Current Therapeutic Research 1994
Viral Hepatitis and Liver Disease
K Nishioka, H Suzuki, S Mishiro, T Oda
1994
The Sclera
CS Foster, MS de la Maza
1994
Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1
SA Jimenez, J Varga, A Olsen, L Li, A Diaz, J Herhal, J Koch
The Journal of biological chemistry 1994
Interferon-α2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection
G Zöhrens, T Armbrust, , G Ramadori
Digestive Diseases and Sciences 1994
Control of Fibrosis in Systemic Scleroderma
C Mauch, B Eckes, N Hunzelmann, T Oono, E Kozlowska, T Krieg
Journal of Investigative Dermatology 1993
Effects of tumor necrosis factor-? on connective tissue metabolism in normal and scleroderma fibroblast cultures
K Takeda, A Hatamochi, M Arakawa, H Ueki
Archives of Dermatological Research 1993
Pathophysiology and Pharmacologic Modulation of Hepatic Fibrosis
CR Leveille, IM Arias
Journal of Veterinary Internal Medicine 1993
New challenges in hepatic fibrosis
B Clément, O Loréal, F Levavasseur, A Guillouzo
Journal of Hepatology 1993
Keloids and Hypertrophic Scars
AJ Nemeth
The Journal of Dermatologic Surgery and Oncology 1993
Toward Rational Treatment of Scleroderma
B Freundlich
Hospital Practice 1993
Pleotrophic action of interferon gamma in human orbital fibroblasts
PJ Higgins, TJ Smith
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1993
Scars and Keloids
JC Murray
Dermatologic Clinics 1993
Interferon-alpha 2b inhibits proliferation of human Tenon's capsule fibroblasts
M Gillies, T Su, M Sarossy, F Hollows
Graefe's Archive for Clinical and Experimental Ophthalmology 1993
Effect of Topical Interferon-Alpha 2b on Corneal Haze After Excimer Laser Photorefractive Keratectomy in Rabbits
N Monet, MC Gillies, R Crouch, A Maloof
Journal of refractive surgery (Thorofare, N.J. : 1995) 1993
Relaxin Alone and in Conjunction with Interferon-gamma Decreases Collagen Synthesis by Cultured Human Scleroderma Fibroblasts
EN Unemori, EA Bauer, EP Amento
Journal of Investigative Dermatology 1992
Treatment of systemic sclerosis with γ-interferon
R Hein, J Behr, M Hundgen, N Hunzelmann, M Meurer, O Braun-Falco, A Urbanski, T Krieg
British Journal of Dermatology 1992
Enhanced wound healing in animal models by interferon and an interferon inducer
D Bhartiya, JW Sklarsh, RK Maheshwari
Journal of Cellular Physiology 1992
Treatment of systemic sclerosis with recombinant interferon-γ. A phase I/II clinical trial
B Freundlich, SA Jimenez, VD Steen, TA Medsger, M Szkolnicki, HS Jaffe
Arthritis & Rheumatism 1992
Inhibition of rat hepatic lipocyte activation in culture by interferon-γ
DC Rockey, JJ Maher, WR Jarnagin, G Gabbiani, SL Friedman
Hepatology 1992
Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures Potential role in fibrosis
P Gillery, C Fertin, JF Nicolas, F Chastang, B Kalis, J Banchereau, FX Maquart
FEBS Letters 1992
Scar Wars Strategies: Target Collagen
SQ Low, RL Moy
The Journal of Dermatologic Surgery and Oncology 1992
Why does liver fibrosis occur in schistosomiasis?
DJ Wyler
Parasitology Today 1992
Lymphocyte-Macrophage Alveolitis in Nonsmoking Individuals Occupationally Exposed to Asbestos
WN Rom, WD Travis
Chest 1992
Effect of γ-Interferon on Collagen Synthesis by Normal and Fibrotic Human Lung Fibroblasts
AS Narayanan, J Whithey, A Souza, G Raghu
Chest 1992
Altered cytokine production in black patients with keloids
RL McCauley, V Chopra, YY Li, DN Herndon, MC Robson
Journal of Clinical Immunology 1992
Collagen synthesis in fibroblasts from human colon: regulatory aspects and differences with skin fibroblasts
MF Martens, CM Huyben, T Hendriks
Gut 1992
Mechanisms of bleomycin-induced lung damage
J Hay, S Shahzeidi, G Laurent
Archives of Toxicology 1991
Regulation of the Proliferation and Biosynthetic Activities of Cultured Human Peyronie's Disease Fibroblasts by Interferons-Alpha, -Beta and -Gamma
MR Duncan, B Berman, UO Nseyo
Scandinavian Journal of Urology and Nephrology 1991
Mechanisms of tubulointerstitial fibrosis
GS Kuncio, EG Neilson, T Haverty
Kidney International 1991
Locally applied GM-CSF induces the accumulation of α-smooth muscle act in containing myofibroblasts
L Rubbia-Brandt, AP Sappino, G Gabbiani
Virchows Archiv B Cell Pathology Including Molecular Pathology 1991
Cytokines, fibrosis and the failure of glaucoma filtration surgery
MC Gillies
Australian and New Zealand Journal of Ophthalmology 1991
Modulation of human dermal fibroblast extracellular matrix metabolism by the lymphokine leukoregulin
A Mauviel, F Rédini, DJ Hartmann, JP Pujol, CH Evans
The Journal of Cell Biology 1991
Rheumatology
RA Asherson, R Cervera, DP D'Cruz, GR Hughes
Postgraduate medical journal 1991
Regulation of Laminin Expression by Interferon
RK Maheshwari, VI Kedar, HC Coon, D Bhartiya
Journal of Interferon Research 1991
Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells
EP Amento, N Ehsani, H Palmer, P Libby
Arteriosclerosis Thrombosis and Vascular Biology 1991
Leucocytes and pulmonary disorders: Mobilization, activation and role in pathology
A Shock, GJ Laurent
Molecular Aspects of Medicine 1990
Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts
J Varga, A Olsen, J Herhal, G Constantine, J Rosenbloom, SA Jimenez
European Journal of Clinical Investigation 1990
Interferon-? Modulates the Effect of Transforming Growth Factor-? on Extracellular Matrix Gene Expression by Fibroblasts
J Varga, A Olsen, SA Jimenez
Annals of the New York Academy of Sciences 1990
Interferons and Collagen Production
RD Granstein, TJ Flotte, EP Amento
Journal of Investigative Dermatology 1990
Regulation of Human Lung Fibroblast Collagen Production by Recombinant Interleukin-1, Tumor Necrosis Factor, and Interferon-?
JA Elias, B Freundlich, S Adams, J Rosenbloom
Annals of the New York Academy of Sciences 1990
Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor- β in normal human fibroblasts
J Varga, A Olsen, J Herhal, G Constantine, J Rosenbloom, SA Jimenez
European Journal of Clinical Investigation 1990
A contra-IL-2 cytokine derived from mice suppressed for collagen-induced arthritis
TF Kresina
Cellular Immunology 1990
Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis
AM Gressner, M Althaus
Biochemical Pharmacology 1990
Peptide Growth Factors and Their Receptors II
MB Sporn, AB Roberts
1990
Immune Aspects of Wound Repair
A Barbul
Clinics in Plastic Surgery 1990
Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene
G Karsenty, B de Crombrugghe
The Journal of biological chemistry 1990
Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts
JG Clark, TF Dedon, EA Wayner, WG Carter
Journal of Clinical Investigation 1989
Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha,-beta, and-gamma
MR Duncan, B Berman
Archives of Dermatological Research 1989
Release of Interleukin 2 and Gamma Interferon by Peripheral Mononuclear Cells in Human Schistosoma mansoni Infection Normalizes after Chemotherapy
K Zwingenberger, E Irschick, JG Vergetti, AR Dacal, R Janssen-Rosseck, U Bienzle, C Huber, H Feldmeier
Scandinavian Journal of Immunology 1989
The Systemic Administration of Gamma Interferon Inhibits Collagen Synthesis and Acute Inflammation in a Murine Skin Wounding Model
RD Granstein, MR Deak, SL Jacques, RJ Margolis, TJ Flotte, D Whitaker, FH Long, EP Amento
Journal of Investigative Dermatology 1989
γ-interferon treatment inhibits collagen deposition in murine schistosomiasis
MJ Czaja, FR Weiner, S Takahashi, MA Giambrone, PH der van Meide, H Schellekens, L Biempica, MA Zern
Hepatology 1989
The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing
A Barbul, RJ Breslin, JP Woodyard, HL Wasserkrug, G Efron
Annals of Surgery 1989
Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells
GK Hansson, M Hellstrand, L Rymo, L Rubbia, G Gabbiani
Journal of Experimental Medicine 1989
Recombinant interferon-γ in the treatment of systemic sclerosis
A Kahan, B Amor, CJ Menkes, G Strauch
The American Journal of Medicine 1989
Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro
B Berman, MR Duncan
Journal of the American Academy of Dermatology 1989
Immune Consequences of Trauma, Shock, and Sepsis
E Faist, JL Ninnemann, DR Green
1989
Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin
JA Elias, RC Krol, B Freundlich, PM Sampson
Journal of Clinical Investigation 1988
Antigen Specific Down Regulation of Murine Collagen Induced Arthritis: T Suppressor Cell Circuits in Arthritis Immunotherapy
TF Kresina
International Reviews of Immunology 1988
Therapeutic strategies for hepatic fibrosis
M Chojkier, DA Brenner
Hepatology 1988
Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors
BJ Nickoloff, RS Mitra, BL Riser, VM Dixit, J Varani
The American Journal of Pathology 1988
Interferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture
VM Kähäri, J Heino, T Vuorio, E Vuorio
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1988
Interferon-alpha-2 in the treatment of idiopathic myelofibrosis
HL Seewann, G Gastl, A Lang, K Abbrederis, J Thaler, R Flener, C Huber
Blut Zeitschrift für die Gesamte Blutforschung 1988
Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts
JA Solis-Herruzo, DA Brenner, M Chojkier
The Journal of biological chemistry 1988
Gamma-interferon inhibits collagen synthesis in vivo in the mouse
RD Granstein, GF Murphy, RJ Margolis, MH Byrne, EP Amento
Journal of Clinical Investigation 1987
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts
R Raghow, AE Postlethwaite, J Keski-Oja, HL Moses, AH Kang
Journal of Clinical Investigation 1987
Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons
MR Duncan, B Berman
Journal of Clinical Investigation 1987
Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effect on their proliferation
Y Ohmori, S Hanazawa, S Amano, T Miyoshi, K Hirose, S Kitano
Infection and immunity 1987
Supernatant from an Activated Human CD4+ T-Cell Clone Modulates the Proliferation and Collagen Synthesis of Human Dental Pulp Fibroblast
M Melin, S Saeland, H Magloire, DJ Hartmann, S Guerret, D Blanchard, J Banchereau, JA Grimaud
Collagen and Related Research 1987
Endogenous gamma interferon production may protect against hepatic cirrhosis and adminstration of exogenous gamma interferon may protect individuals prone to cirrhosis
RJ Sharpe
Medical Hypotheses 1987
Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells
MB Goldring, SM Krane
The Journal of biological chemistry 1987
Differential effects of gamma-interferon on collagen and fibronectin gene expression
MJ Czaja, FR Weiner, M Eghbali, MA Giambrone, M Eghbali, MA Zern
The Journal of biological chemistry 1987
Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ-interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels
J Rosenbloom, G Feldman, B Freundlich, SA Jimenez
Arthritis & Rheumatism 1986
Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma
M Gowen, GE Nedwin, GR Mundy
Journal of Bone and Mineral Research 1986
Cell-mediated immunity in rheumatic disease
SJ Padula, RB Clark, JH Korn
Human Pathology 1986
Regulation of fibroblast proliferation and collagen synthesis by cytokines
B freundlich, JS Bomalaski, E Neilson, SA Jimenez
Immunology Today 1986
Fibrotic reactions in the lung: the activation of the lung fibroblast
R H Goldstein, A Fine
Experimental Lung Research 1986
Rheumatoid Arthritis: Clinical Features and Pathogenetic Mechanisms
SM Krane, LS Simon
Medical Clinics of North America 1986
Pulmonary Sequelae and Lung Repair in Survivors of the Adult Respiratory Distress Syndrome
DH Ingbar, RA Matthay
Critical Care Clinics 1986
Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes
MB Goldring, LJ Sandell, ML Stephenson, SM Krane
The Journal of biological chemistry 1986
Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis
EP Amento, AK Bhan, KG McCullagh, SM Krane
Journal of Clinical Investigation 1985
The Role of Lymphokines and Monokines in Fibrosis
SM Wahl
Annals of the New York Academy of Sciences 1985
Transcriptional Control of Human Diploid Fibroblast Collagen Synthesis by ?-Interferon
SA Jimenez, J Rosenbloom
Annals of the New York Academy of Sciences 1985
Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation
MR Duncan, B Berman
Journal of Experimental Medicine 1985
Mononuclear Cell-Conditioned Medium Containing Mononuclear Cell Factor (MCF), Homologous With Interleukin 1, Stimulates Collagen and Fibronectin Synthesis by Adherent Rheumatoid Synovial Cells: Effects of Prostaglandin E2 and Indomethacin
SM Krane, JM Dayer, LS Simon, MS Byrne
Collagen and Related Research 1985
Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated wth decreaded levels of the procollagen mRNAs(FEBS 2156)
ML Stephenson, SM Krane, EP Amento, PA McCroskery, M Byrne
FEBS Letters 1985

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
29 readers on Mendeley
See more details